glp 1 agonist and dementia Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders Incretin and insulin signaling as

The MS conditions used for Q-TOF were as follows: nebulizer, 1.0 bar

In vivo studies showed that 59 exhibited the strongest antihyperuricemia and renal protective activity, effectively lowering serum uric acid levels in mice with hyperuricemia by inhibiting XO activity and also effectively reducing urate accumulation in the kidney

The dorsal root ganglia (DRG) and spinal cords (SC) were collected, and then, the number of cytokine-positive cells was determined via immunostaining

Biomolecules 10 , 687 (2020)

Possible mild side effects include injection site irritation, mild swelling, or dizziness

J Biol Chem 246:402411 Shug AL, Shrago E, Bittar N, Folts JD, Koke JR (1975) Acyl-CoA inhibition of adenine nucleotide translocation in ischemic myocardium